REGION VÄSTERBOTTEN
🇧🇪Belgium
- Country
- 🇧🇪Belgium
- Ownership
- Private
- Established
- 1863-01-01
- Employees
- -
- Market Cap
- -
Clinical Trials
18
Active:4
Completed:2
Trial Phases
4 Phases
Phase 1:3
Phase 3:1
Phase 4:1
+1 more phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (14 trials with phase data)• Click on a phase to view related trials
Not Applicable
9 (64.3%)Phase 1
3 (21.4%)Phase 3
1 (7.1%)Phase 4
1 (7.1%)Male Lichen Sclerosus - Risk Factors, Treatment, and Impact on Quality of Life
Not yet recruiting
- Conditions
- Lichen Sclerosus
- First Posted Date
- 2025-05-22
- Last Posted Date
- 2025-05-22
- Lead Sponsor
- Region Västerbotten
- Target Recruit Count
- 370
- Registration Number
- NCT06984263
Composed Abdominal Wall Analysis. Collecting Tissue and Blood From Patients Undergoing Elective Laparosopic Cholecystectomy. Objective to Describe the Normal Abdominal Wall
- Conditions
- HerniaAbdominal Wall
- First Posted Date
- 2024-12-04
- Last Posted Date
- 2024-12-04
- Lead Sponsor
- Region Västerbotten
- Target Recruit Count
- 40
- Registration Number
- NCT06717061
- Locations
- 🇸🇪
Kirurgcentrum Västerbotten, Skellefteå, Sweden
Evaluation of PSMA-PET and mpMRI in High-risk Prostate Cancer - Using Histopathologic Validation
Phase 3
Recruiting
- Conditions
- Prostate Cancer
- Interventions
- Drug: [18F]PSMA-PETDevice: MRI sequences optimized for prostate cancer examinations
- First Posted Date
- 2024-08-21
- Last Posted Date
- 2025-03-04
- Lead Sponsor
- Region Västerbotten
- Target Recruit Count
- 60
- Registration Number
- NCT06565247
- Locations
- 🇸🇪
Region Skåne, Malmö, Sweden
🇸🇪Region Västerbotten, Umeå, Sweden
Different Forms of OMT as Methods for Reducing Snoring and Mild to Moderate Sleep Apnea
Not Applicable
- Conditions
- Sleep Apnea, ObstructiveSnoring
- First Posted Date
- 2024-03-26
- Last Posted Date
- 2025-01-29
- Lead Sponsor
- Region Västerbotten
- Target Recruit Count
- 141
- Registration Number
- NCT06330116
- Locations
- 🇩🇰
Zealand University Hospital, Köge, Sjaelland, Denmark
🇸🇪Skåne University Hospital, Lund, Skåne, Sweden
🇸🇪Region Västerbotten, Umeå, Västerbotten, Sweden
Prognostic and Diagnostic Added Value of Medical Imaging in Gynecological Cancer (PRODIGYN)
Recruiting
- Conditions
- Epithelial Ovarian CancerEndometrial CancerCervix Cancer
- First Posted Date
- 2023-05-12
- Last Posted Date
- 2024-12-16
- Lead Sponsor
- Region Västerbotten
- Target Recruit Count
- 120
- Registration Number
- NCT05855941
- Locations
- 🇸🇪
Centre for Gynecology and Obstetrics, Umea University Hospital, Umea, Sweden
- Prev
- 1
- 2
- 3
- Next
News
No news found